Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome

The New England Journal of Medicine
Orrin DevinskyGWPCARE3 Study Group

Abstract

Cannabidiol has been used for treatment-resistant seizures in patients with severe early-onset epilepsy. We investigated the efficacy and safety of cannabidiol added to a regimen of conventional antiepileptic medication to treat drop seizures in patients with the Lennox-Gastaut syndrome, a severe developmental epileptic encephalopathy. In this double-blind, placebo-controlled trial conducted at 30 clinical centers, we randomly assigned patients with the Lennox-Gastaut syndrome (age range, 2 to 55 years) who had had two or more drop seizures per week during a 28-day baseline period to receive cannabidiol oral solution at a dose of either 20 mg per kilogram of body weight (20-mg cannabidiol group) or 10 mg per kilogram (10-mg cannabidiol group) or matching placebo, administered in two equally divided doses daily for 14 weeks. The primary outcome was the percentage change from baseline in the frequency of drop seizures (average per 28 days) during the treatment period. A total of 225 patients were enrolled; 76 patients were assigned to the 20-mg cannabidiol group, 73 to the 10-mg cannabidiol group, and 76 to the placebo group. During the 28-day baseline period, the median number of drop seizures was 85 in all trial groups combined...Continue Reading

References

May 1, 1997·Epilepsia·H Heiskala
Aug 4, 2011·Epilepsia·Peter R Camfield
Oct 1, 2011·Neurology·Y T NgUNKNOWN OV-1012 Study Investigators
Nov 13, 2012·Epilepsy & Behavior : E&B·Yu-Tze NgUNKNOWN OV-1004 study investigators
May 3, 2014·Therapeutic Advances in Neurological Disorders·Gabriela Purcarin, Yu-Tze Ng
Jan 27, 2015·Epilepsy Research·Hyo Jeong KimHoon-Chul Kang
Jun 27, 2015·Epilepsia·Alexandra L GeffreyElizabeth A Thiele
Jan 3, 2016·Lancet Neurology·Orrin DevinskyMaria Roberta Cilio
May 26, 2017·The New England Journal of Medicine·Orrin DevinskyUNKNOWN Cannabidiol in Dravet Syndrome Study Group
Mar 16, 2018·Neurology·Orrin DevinskyUNKNOWN GWPCARE1 Part A Study Group

❮ Previous
Next ❯

Citations

Aug 23, 2018·The New England Journal of Medicine·Orrin DevinskyKevan E VanLandingham
Aug 9, 2018·British Journal of Clinical Pharmacology·John A Lawson, Ingrid E Scheffer
Sep 29, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Natascia BruniFranco Dosio
Nov 8, 2018·Developmental Medicine and Child Neurology·Shayma AliLynette G Sadleir
Oct 20, 2018·Practical Neurology·Rhys H Thomas, Mark O Cunningham
Dec 6, 2018·Epilepsia·Jesse ElliottGeorge A Wells
Jan 9, 2019·The Annals of Pharmacotherapy·Jeffrey W ChenAllison B Blackmer
Feb 8, 2019·Journal of Clinical Pharmacology·C Michael White
Feb 13, 2019·International Journal of Molecular Sciences·Shaip Krasniqi, Armond Daci
Feb 16, 2019·Expert Review of Clinical Pharmacology·Nienke HalbmeijerLissy De Ridder
Mar 1, 2019·JAAPA : Official Journal of the American Academy of Physician Assistants·Kathryn M LaFleur, Eric C Nemec
Mar 29, 2019·Continuum : Lifelong Learning in Neurology·Bassel W Abou-Khalil
Jan 31, 2019·Alcoholism, Clinical and Experimental Research·Jasmine TurnaJames MacKillop
Apr 12, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Gabriella Gobbi
Apr 18, 2019·Expert Opinion on Drug Metabolism & Toxicology·Barbara MiziakStanisław J Czuczwar
May 3, 2019·Epilepsy Currents·Barbara C JobstFred Lado
Jun 13, 2019·The New England Journal of Medicine·Pieter A Cohen, Joshua Sharfstein
Jun 22, 2019·British Journal of Clinical Pharmacology·S A MillarS E O'Sullivan
Mar 4, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Sandra WahbyColin Bruce Josephson
Aug 3, 2019·Expert Opinion on Pharmacotherapy·Frank M C Besag, Michael J Vasey
Sep 11, 2019·The Journal of Clinical Investigation·Bin GuBenjamin D Philpot
Dec 8, 2019·International Journal of Molecular Sciences·Keith A Kwan CheungMurray D Mitchell
Oct 29, 2019·British Journal of Clinical Pharmacology·Kirsten Riber BergmannGeert Jan Groeneveld
Dec 29, 2019·Antioxidants·Sinemyiz AtalayElzbieta Skrzydlewska
Jan 7, 2020·Epilepsia·J Helen CrossLieven Lagae
Jan 9, 2020·Paediatric Drugs·Emma van der Poest ClementJurriaan M Peters
Jan 24, 2020·Current Opinion in Nephrology and Hypertension·Joshua L Rein
Dec 5, 2019·British Journal of Pharmacology·Elizabeth M WilliamsonAngelo A Izzo
Jul 11, 2019·British Journal of Clinical Pharmacology·Geert Jan Groeneveld, Jennifer H Martin
Sep 13, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sonja Elsaid, Bernard Le Foll
Aug 2, 2019·Current Neuropharmacology·Eric Murillo-RodríguezPablo Torterolo
Feb 23, 2020·Critical Care Nursing Quarterly·Kent A OwusuJeffrey Mucksavage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Orrin DevinskyCannabidiol in Dravet Syndrome Study Group
The New England Journal of Medicine
Scott W PowersCHAMP Investigators
The New England Journal of Medicine
Christine Léauté-LabrèzeJean-Jacques Voisard
© 2022 Meta ULC. All rights reserved